ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bupivacaine Extended-Release Liposome Injection Market Research Report 2026
Published Date: 2026-01-21
|
Report Code: QYRE-Auto-10L20096
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Bupivacaine Extended Release Liposome Injection Market Outlook In Depth Analysis Forecast to 2031
BUY CHAPTERS

Global Bupivacaine Extended-Release Liposome Injection Market Research Report 2026

Code: QYRE-Auto-10L20096
Report
2026-01-21
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pacira Pharmaceuticals
Jiangsu Hengrui Pharm

Bupivacaine Extended-Release Liposome Injection Market Size

The global Bupivacaine Extended-Release Liposome Injection market was valued at US$ 372 million in 2025 and is anticipated to reach US$ 507 million by 2032, at a CAGR of 4.6% from 2026 to 2032.

Bupivacaine Extended-Release Liposome Injection Market

Bupivacaine Extended-Release Liposome Injection Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Bupivacaine Extended-Release Liposome Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Bupivacaine liposome injection is a special formulation that encapsulates the local anesthetic bupivacaine within liposomes. This delivery system allows for prolonged and controlled release of bupivacaine, thereby extending the duration of its anesthetic effect.
The North American market for Bupivacaine Extended-Release Liposome Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Bupivacaine Extended-Release Liposome Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Bupivacaine Extended-Release Liposome Injection include Pacira Pharmaceuticals, Jiangsu Hengrui Pharm, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Bupivacaine Extended-Release Liposome Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Bupivacaine Extended-Release Liposome Injection. The Bupivacaine Extended-Release Liposome Injection market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Bupivacaine Extended-Release Liposome Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Bupivacaine Extended-Release Liposome Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Bupivacaine Extended-Release Liposome Injection Market Report

Report Metric Details
Report Name Bupivacaine Extended-Release Liposome Injection Market
Accounted market size in 2025 US$ 372 million
Forecasted market size in 2032 US$ 507 million
CAGR 4.6%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • 133mg Per Vial
  • 266mg Per Vial
by Application
  • Local Anesthesia
  • Postoperative Analgesia
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pacira Pharmaceuticals, Jiangsu Hengrui Pharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Bupivacaine Extended-Release Liposome Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Bupivacaine Extended-Release Liposome Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Bupivacaine Extended-Release Liposome Injection Market growing?

Ans: The Bupivacaine Extended-Release Liposome Injection Market witnessing a CAGR of 4.6% during the forecast period 2026-2032.

What is the Bupivacaine Extended-Release Liposome Injection Market size in 2032?

Ans: The Bupivacaine Extended-Release Liposome Injection Market size in 2032 will be US$ 507 million.

Who are the main players in the Bupivacaine Extended-Release Liposome Injection Market report?

Ans: The main players in the Bupivacaine Extended-Release Liposome Injection Market are Pacira Pharmaceuticals, Jiangsu Hengrui Pharm

What are the Application segmentation covered in the Bupivacaine Extended-Release Liposome Injection Market report?

Ans: The Applications covered in the Bupivacaine Extended-Release Liposome Injection Market report are Local Anesthesia, Postoperative Analgesia, Other

What are the Type segmentation covered in the Bupivacaine Extended-Release Liposome Injection Market report?

Ans: The Types covered in the Bupivacaine Extended-Release Liposome Injection Market report are 133mg Per Vial, 266mg Per Vial

1 Bupivacaine Extended-Release Liposome Injection Market Overview
1.1 Product Definition
1.2 Bupivacaine Extended-Release Liposome Injection by Type
1.2.1 Global Bupivacaine Extended-Release Liposome Injection Market Value by Type: 2025 vs 2032
1.2.2 133mg Per Vial
1.2.3 266mg Per Vial
1.3 Bupivacaine Extended-Release Liposome Injection by Application
1.3.1 Global Bupivacaine Extended-Release Liposome Injection Market Value by Application: 2025 vs 2032
1.3.2 Local Anesthesia
1.3.3 Postoperative Analgesia
1.3.4 Other
1.4 Global Bupivacaine Extended-Release Liposome Injection Market Size Estimates and Forecasts
1.4.1 Global Bupivacaine Extended-Release Liposome Injection Revenue 2021–2032
1.4.2 Global Bupivacaine Extended-Release Liposome Injection Sales 2021–2032
1.4.3 Global Bupivacaine Extended-Release Liposome Injection Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Bupivacaine Extended-Release Liposome Injection Market Competition by Manufacturers
2.1 Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Bupivacaine Extended-Release Liposome Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Bupivacaine Extended-Release Liposome Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Bupivacaine Extended-Release Liposome Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Bupivacaine Extended-Release Liposome Injection, Product Types and Applications
2.7 Global Key Manufacturers of Bupivacaine Extended-Release Liposome Injection, Date of Entry into the Industry
2.8 Global Bupivacaine Extended-Release Liposome Injection Market Competitive Situation and Trends
2.8.1 Global Bupivacaine Extended-Release Liposome Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Bupivacaine Extended-Release Liposome Injection Players Market Share by Revenue
2.8.3 Global Bupivacaine Extended-Release Liposome Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Bupivacaine Extended-Release Liposome Injection Market Scenario by Region
3.1 Global Bupivacaine Extended-Release Liposome Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Bupivacaine Extended-Release Liposome Injection Sales by Region: 2021–2032
3.2.1 Global Bupivacaine Extended-Release Liposome Injection Sales by Region: 2021–2026
3.2.2 Global Bupivacaine Extended-Release Liposome Injection Sales by Region: 2027–2032
3.3 Global Bupivacaine Extended-Release Liposome Injection Revenue by Region: 2021–2032
3.3.1 Global Bupivacaine Extended-Release Liposome Injection Revenue by Region: 2021–2026
3.3.2 Global Bupivacaine Extended-Release Liposome Injection Revenue by Region: 2027–2032
3.4 North America Bupivacaine Extended-Release Liposome Injection Market Facts & Figures by Country
3.4.1 North America Bupivacaine Extended-Release Liposome Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Bupivacaine Extended-Release Liposome Injection Sales by Country (2021–2032)
3.4.3 North America Bupivacaine Extended-Release Liposome Injection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bupivacaine Extended-Release Liposome Injection Market Facts & Figures by Country
3.5.1 Europe Bupivacaine Extended-Release Liposome Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Bupivacaine Extended-Release Liposome Injection Sales by Country (2021–2032)
3.5.3 Europe Bupivacaine Extended-Release Liposome Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bupivacaine Extended-Release Liposome Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Bupivacaine Extended-Release Liposome Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Bupivacaine Extended-Release Liposome Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific Bupivacaine Extended-Release Liposome Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Bupivacaine Extended-Release Liposome Injection Market Facts & Figures by Country
3.7.1 Latin America Bupivacaine Extended-Release Liposome Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Bupivacaine Extended-Release Liposome Injection Sales by Country (2021–2032)
3.7.3 Latin America Bupivacaine Extended-Release Liposome Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Bupivacaine Extended-Release Liposome Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Bupivacaine Extended-Release Liposome Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Bupivacaine Extended-Release Liposome Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Bupivacaine Extended-Release Liposome Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bupivacaine Extended-Release Liposome Injection Sales by Type (2021–2032)
4.1.1 Global Bupivacaine Extended-Release Liposome Injection Sales by Type (2021–2026)
4.1.2 Global Bupivacaine Extended-Release Liposome Injection Sales by Type (2027–2032)
4.1.3 Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Type (2021–2032)
4.2 Global Bupivacaine Extended-Release Liposome Injection Revenue by Type (2021–2032)
4.2.1 Global Bupivacaine Extended-Release Liposome Injection Revenue by Type (2021–2026)
4.2.2 Global Bupivacaine Extended-Release Liposome Injection Revenue by Type (2027–2032)
4.2.3 Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Type (2021–2032)
4.3 Global Bupivacaine Extended-Release Liposome Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Bupivacaine Extended-Release Liposome Injection Sales by Application (2021–2032)
5.1.1 Global Bupivacaine Extended-Release Liposome Injection Sales by Application (2021–2026)
5.1.2 Global Bupivacaine Extended-Release Liposome Injection Sales by Application (2027–2032)
5.1.3 Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Application (2021–2032)
5.2 Global Bupivacaine Extended-Release Liposome Injection Revenue by Application (2021–2032)
5.2.1 Global Bupivacaine Extended-Release Liposome Injection Revenue by Application (2021–2026)
5.2.2 Global Bupivacaine Extended-Release Liposome Injection Revenue by Application (2027–2032)
5.2.3 Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Application (2021–2032)
5.3 Global Bupivacaine Extended-Release Liposome Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pacira Pharmaceuticals
6.1.1 Pacira Pharmaceuticals Company Information
6.1.2 Pacira Pharmaceuticals Description and Business Overview
6.1.3 Pacira Pharmaceuticals Bupivacaine Extended-Release Liposome Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pacira Pharmaceuticals Bupivacaine Extended-Release Liposome Injection Product Portfolio
6.1.5 Pacira Pharmaceuticals Recent Developments/Updates
6.2 Jiangsu Hengrui Pharm
6.2.1 Jiangsu Hengrui Pharm Company Information
6.2.2 Jiangsu Hengrui Pharm Description and Business Overview
6.2.3 Jiangsu Hengrui Pharm Bupivacaine Extended-Release Liposome Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Jiangsu Hengrui Pharm Bupivacaine Extended-Release Liposome Injection Product Portfolio
6.2.5 Jiangsu Hengrui Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bupivacaine Extended-Release Liposome Injection Industry Chain Analysis
7.2 Bupivacaine Extended-Release Liposome Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bupivacaine Extended-Release Liposome Injection Production Mode & Process Analysis
7.4 Bupivacaine Extended-Release Liposome Injection Sales and Marketing
7.4.1 Bupivacaine Extended-Release Liposome Injection Sales Channels
7.4.2 Bupivacaine Extended-Release Liposome Injection Distributors
7.5 Bupivacaine Extended-Release Liposome Injection Customer Analysis
8 Bupivacaine Extended-Release Liposome Injection Market Dynamics
8.1 Bupivacaine Extended-Release Liposome Injection Industry Trends
8.2 Bupivacaine Extended-Release Liposome Injection Market Drivers
8.3 Bupivacaine Extended-Release Liposome Injection Market Challenges
8.4 Bupivacaine Extended-Release Liposome Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pacira Pharmaceuticals
Jiangsu Hengrui Pharm
List of Tables
 Table 1. Global Bupivacaine Extended-Release Liposome Injection Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Bupivacaine Extended-Release Liposome Injection Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Bupivacaine Extended-Release Liposome Injection Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Bupivacaine Extended-Release Liposome Injection Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Bupivacaine Extended-Release Liposome Injection Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Bupivacaine Extended-Release Liposome Injection Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Bupivacaine Extended-Release Liposome Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Bupivacaine Extended-Release Liposome Injection, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Bupivacaine Extended-Release Liposome Injection, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Bupivacaine Extended-Release Liposome Injection, Product Types and Applications
 Table 12. Global Key Manufacturers of Bupivacaine Extended-Release Liposome Injection, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Bupivacaine Extended-Release Liposome Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Bupivacaine Extended-Release Liposome Injection Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Bupivacaine Extended-Release Liposome Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Bupivacaine Extended-Release Liposome Injection Sales by Region (K Units), 2021–2026
 Table 18. Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Region (2021–2026)
 Table 19. Global Bupivacaine Extended-Release Liposome Injection Sales by Region (K Units), 2027–2032
 Table 20. Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Region (2027–2032)
 Table 21. Global Bupivacaine Extended-Release Liposome Injection Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Region (2021–2026)
 Table 23. Global Bupivacaine Extended-Release Liposome Injection Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Region (2027–2032)
 Table 25. North America Bupivacaine Extended-Release Liposome Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Bupivacaine Extended-Release Liposome Injection Sales by Country (K Units), 2021–2026
 Table 27. North America Bupivacaine Extended-Release Liposome Injection Sales by Country (K Units), 2027–2032
 Table 28. North America Bupivacaine Extended-Release Liposome Injection Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Bupivacaine Extended-Release Liposome Injection Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Bupivacaine Extended-Release Liposome Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Bupivacaine Extended-Release Liposome Injection Sales by Country (K Units), 2021–2026
 Table 32. Europe Bupivacaine Extended-Release Liposome Injection Sales by Country (K Units), 2027–2032
 Table 33. Europe Bupivacaine Extended-Release Liposome Injection Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Bupivacaine Extended-Release Liposome Injection Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Bupivacaine Extended-Release Liposome Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Bupivacaine Extended-Release Liposome Injection Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Bupivacaine Extended-Release Liposome Injection Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Bupivacaine Extended-Release Liposome Injection Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Bupivacaine Extended-Release Liposome Injection Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Bupivacaine Extended-Release Liposome Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Bupivacaine Extended-Release Liposome Injection Sales by Country (K Units), 2021–2026
 Table 42. Latin America Bupivacaine Extended-Release Liposome Injection Sales by Country (K Units), 2027–2032
 Table 43. Latin America Bupivacaine Extended-Release Liposome Injection Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Bupivacaine Extended-Release Liposome Injection Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Bupivacaine Extended-Release Liposome Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Bupivacaine Extended-Release Liposome Injection Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Bupivacaine Extended-Release Liposome Injection Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Bupivacaine Extended-Release Liposome Injection Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Bupivacaine Extended-Release Liposome Injection Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Bupivacaine Extended-Release Liposome Injection Sales (K Units) by Type (2021–2026)
 Table 51. Global Bupivacaine Extended-Release Liposome Injection Sales (K Units) by Type (2027–2032)
 Table 52. Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Type (2021–2026)
 Table 53. Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Type (2027–2032)
 Table 54. Global Bupivacaine Extended-Release Liposome Injection Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Bupivacaine Extended-Release Liposome Injection Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Type (2021–2026)
 Table 57. Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Type (2027–2032)
 Table 58. Global Bupivacaine Extended-Release Liposome Injection Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Bupivacaine Extended-Release Liposome Injection Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Bupivacaine Extended-Release Liposome Injection Sales (K Units) by Application (2021–2026)
 Table 61. Global Bupivacaine Extended-Release Liposome Injection Sales (K Units) by Application (2027–2032)
 Table 62. Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Application (2021–2026)
 Table 63. Global Bupivacaine Extended-Release Liposome Injection Sales Market Share by Application (2027–2032)
 Table 64. Global Bupivacaine Extended-Release Liposome Injection Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Bupivacaine Extended-Release Liposome Injection Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Application (2021–2026)
 Table 67. Global Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Application (2027–2032)
 Table 68. Global Bupivacaine Extended-Release Liposome Injection Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Bupivacaine Extended-Release Liposome Injection Price (US$/Unit) by Application (2027–2032)
 Table 70. Pacira Pharmaceuticals Company Information
 Table 71. Pacira Pharmaceuticals Description and Business Overview
 Table 72. Pacira Pharmaceuticals Bupivacaine Extended-Release Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Pacira Pharmaceuticals Bupivacaine Extended-Release Liposome Injection Product
 Table 74. Pacira Pharmaceuticals Recent Developments/Updates
 Table 75. Jiangsu Hengrui Pharm Company Information
 Table 76. Jiangsu Hengrui Pharm Description and Business Overview
 Table 77. Jiangsu Hengrui Pharm Bupivacaine Extended-Release Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Jiangsu Hengrui Pharm Bupivacaine Extended-Release Liposome Injection Product
 Table 79. Jiangsu Hengrui Pharm Recent Developments/Updates
 Table 80. Key Raw Materials Lists
 Table 81. Raw Materials Key Suppliers Lists
 Table 82. Bupivacaine Extended-Release Liposome Injection Distributors List
 Table 83. Bupivacaine Extended-Release Liposome Injection Customers List
 Table 84. Bupivacaine Extended-Release Liposome Injection Market Trends
 Table 85. Bupivacaine Extended-Release Liposome Injection Market Drivers
 Table 86. Bupivacaine Extended-Release Liposome Injection Market Challenges
 Table 87. Bupivacaine Extended-Release Liposome Injection Market Restraints
 Table 88. Research Programs/Design for This Report
 Table 89. Key Data Information from Secondary Sources
 Table 90. Key Data Information from Primary Sources
 Table 91. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Bupivacaine Extended-Release Liposome Injection
 Figure 2. Global Bupivacaine Extended-Release Liposome Injection Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Bupivacaine Extended-Release Liposome Injection Market Share by Type: 2025 & 2032
 Figure 4. 133mg Per Vial Product Picture
 Figure 5. 266mg Per Vial Product Picture
 Figure 6. Global Bupivacaine Extended-Release Liposome Injection Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Bupivacaine Extended-Release Liposome Injection Market Share by Application: 2025 & 2032
 Figure 8. Local Anesthesia
 Figure 9. Postoperative Analgesia
 Figure 10. Other
 Figure 11. Global Bupivacaine Extended-Release Liposome Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Bupivacaine Extended-Release Liposome Injection Market Size (US$ Million), 2021–2032
 Figure 13. Global Bupivacaine Extended-Release Liposome Injection Sales (K Units), 2021–2032
 Figure 14. Global Bupivacaine Extended-Release Liposome Injection Average Price (US$/Unit), 2021–2032
 Figure 15. Bupivacaine Extended-Release Liposome Injection Report Years Considered
 Figure 16. Bupivacaine Extended-Release Liposome Injection Sales Share by Manufacturers in 2025
 Figure 17. Global Bupivacaine Extended-Release Liposome Injection Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Bupivacaine Extended-Release Liposome Injection Players: Market Share by Revenue in Bupivacaine Extended-Release Liposome Injection in 2025
 Figure 19. Bupivacaine Extended-Release Liposome Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Bupivacaine Extended-Release Liposome Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Bupivacaine Extended-Release Liposome Injection Sales Market Share by Country (2021–2032)
 Figure 22. North America Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Country (2021–2032)
 Figure 23. United States Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Bupivacaine Extended-Release Liposome Injection Sales Market Share by Country (2021–2032)
 Figure 26. Europe Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Bupivacaine Extended-Release Liposome Injection Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Region (2021–2032)
 Figure 34. China Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Bupivacaine Extended-Release Liposome Injection Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Bupivacaine Extended-Release Liposome Injection Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Bupivacaine Extended-Release Liposome Injection Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Bupivacaine Extended-Release Liposome Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Bupivacaine Extended-Release Liposome Injection by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Bupivacaine Extended-Release Liposome Injection by Type (2021–2032)
 Figure 54. Global Bupivacaine Extended-Release Liposome Injection Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Bupivacaine Extended-Release Liposome Injection by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Bupivacaine Extended-Release Liposome Injection by Application (2021–2032)
 Figure 57. Global Bupivacaine Extended-Release Liposome Injection Price (US$/Unit) by Application (2021–2032)
 Figure 58. Bupivacaine Extended-Release Liposome Injection Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions